Profile | GDS2987 / GI_39573715-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 17.5 | 51 |
GSM215244 | HMVEC_vehicle_rep2 | 15 | 36 |
GSM215253 | HMVEC_vehicle_rep3 | 26.1 | 60 |
GSM215254 | HMVEC_atorvastatin_rep1 | 264.3 | 85 |
GSM215282 | HMVEC_atorvastatin_rep3 | 229.5 | 83 |
GSM215344 | HMVEC_atorvastatin_rep2 | 255.5 | 84 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 27.2 | 47 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 69.2 | 71 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 87.5 | 73 |
GSM215294 | HMVEC_SLx2119_rep1 | 15 | 47 |
GSM215295 | HMVEC_SLx2119_rep2 | 37.4 | 58 |
GSM215296 | HMVEC_SLx2119_rep3 | 43 | 57 |
GSM215297 | PASMC_vehicle_rep1 | 37.9 | 50 |
GSM215298 | PASMC_vehicle_rep2 | 58.9 | 64 |
GSM215310 | PASMC_vehicle_rep3 | 51 | 61 |
GSM215311 | PASMC_atorvastatin_rep1 | 22.8 | 38 |
GSM215312 | PASMC_atorvastatin_rep2 | 37.8 | 51 |
GSM215313 | PASMC_atorvastatin_rep3 | 47 | 56 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 33.7 | 49 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 26.3 | 45 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 40.7 | 56 |
GSM215327 | PASMC_SLx2119_rep1 | 73 | 70 |
GSM215328 | PASMC_SLx2119_rep2 | 26.7 | 44 |
GSM215329 | PASMC_SLx2119_rep3 | 23.5 | 42 |
GSM215330 | Fibroblasts_vehicle_rep1 | 1.9 | 5 |
GSM215331 | Fibroblasts_vehicle_rep2 | 20.6 | 49 |
GSM215332 | Fibroblasts_vehicle_rep3 | 7.1 | 24 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 23.2 | 51 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 21.6 | 50 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 21.8 | 47 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 33.3 | 64 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 20.9 | 54 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 6.1 | 17 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 6.8 | 20 |
GSM215340 | Fibroblasts_SLx2119_rep2 | ||
GSM215341 | Fibroblasts_SLx2119_rep3 | 28.2 | 56 |